David Degen
6Patents
2h-index
5Co-inventors
36Inventor score
Filing activity: Mar 19, 2012 → Feb 17, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9415112B2 | Bipartite inhibitors of bacterial RNA polymerase | Emerging Cross-Sectional Technologies | 2 | Active |
| US9605028B2 | Antibacterial agents: salinamide derivatives | Physics | 2 | Active |
| US9221880B2 | Antibacterial agents: salinamide derivatives | Physics | 2 | Active |
| US10010619B2 | Bipartite inhibitors of bacterial RNA polymerase | Emerging Cross-Sectional Technologies | 1 | Active |
| US9060970B2 | Bridge-helix cap: target and method for inhibition of bacterial RNA polymerase | Emerging Cross-Sectional Technologies | 0 | Active |
| US9809626B2 | Antibacterial agents: salinamide derivatives | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.